SRSF9 and adrenal cortex carcinoma: Our survival analysis revealed that high expression of SRSF9 was clearly linked with poor prognosis in ACC, LGG, LIHC, KIRC, KIRP, PRAD, PCPG, and UVM, with exception for OV, THCA, and THYM.